Peripheral monocyte count: an independent diagnostic and prognostic biomarker for prostate cancer - a large Chinese cohort study

about

Peripheral monocyte count: an independent diagnostic and prognostic biomarker for prostate cancer - a large Chinese cohort study

Item

http://www.wikidata.org/entity/Q41486852

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Peripheral monocyte count: an ...... - a large Chinese cohort study

@en

type

Item

label

Peripheral monocyte count: an ...... - a large Chinese cohort study

@en

prefLabel

Peripheral monocyte count: an ...... - a large Chinese cohort study

@en

P1476

Peripheral monocyte count: an ...... - a large Chinese cohort study

@en

P2093

Bai-Jun Dong

http://www.w3.org/2001/XMLSchema#string

Fan Xu

http://www.w3.org/2001/XMLSchema#string

Jia-Hua Pan

http://www.w3.org/2001/XMLSchema#string

Jian-Jun Sha

http://www.w3.org/2001/XMLSchema#string

Qiang Liu

http://www.w3.org/2001/XMLSchema#string

Wei Xue

http://www.w3.org/2001/XMLSchema#string

Xiao-Guang Shao

http://www.w3.org/2001/XMLSchema#string

Yan-Qing Wang

http://www.w3.org/2001/XMLSchema#string

Yi-Ran Huang

http://www.w3.org/2001/XMLSchema#string

Yin-Jie Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue-resident macrophages

Cancer statistics, 2015

Prostate cancer and inflammation: the evidence.

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection.

Can urinary PCA3 supplement PSA in the early detection of prostate cancer?

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.

A robust blood gene expression-based prognostic model for castration-resistant prostate cancer

Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study.

EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

P304

579-585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1008-682X.186185

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27569002

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5566853

http://www.w3.org/2001/XMLSchema#string